TrialJournal of thrombosis and thrombolysis2014

Impact of telavancin on prothrombin time and activated partial thromboplastin time as determined using point-of-care coagulometers.

Michael P Ero et al.PubMed ↗Publisher ↗

No numbers read from the abstract.